Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy.

Authors:
Ye J; Zhang J; Zhu Y; Wang L; Jiang X and 2 more

Journal:
Acta Pharm Sin B

Publication Year: 2023

DOI:
10.1016/j.apsb.2023.08.008

PMCID:
PMC10692397

PMID:
38045051

Journal Information

Full Title: Acta Pharm Sin B

Abbreviation: Acta Pharm Sin B

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (Grant Nos. 22177084 and 82173666), Sichuan Science and Technology Program (Grant No. 2022YFQ0054, China), and the Open Research Fund of Chengdu University of Traditional Chinese Medicine State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China. We also thank some materials in the graphical abstract and figures that are produced by BioRender (https://biorender.com). Bo Liu: Project administration, Supervision, Funding acquisition. Gu He: Conceptualization, Methodology, Supervision. Jing Ye: Data curation, Writing-Original Draft, Visualization. Jin Zhang: Writing-Review & Editing, Visualization. Yanghui Zhu: Data Curation. Lian Wang: Visualization. Xian Jiang: Supervision."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025